retatrutide triple agonist weight loss trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v Lilly orforglipron oral GLP-1 phase

Were honored to welcome patients who travel across for our expert, results-driven aesthetic care

Just as your own body and dreams are distinct and discerning, so too is Dr

This article outlines what is currently known about retatrutide's adverse effects, addresses questions around libido and sexual health, and explains when to seek medical advice in the UK context

This typically happens through asynchronous messaging in the patient portal rather than a live video call

Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice

Diabetics notoriously cannot lose weight compared to non-diabetics, so this is genuinely an exciting development for them, especially when you combine this data with the side effect profile